IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 36 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,151,000 | – | 1,805,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 11,901 | $11,946,000 | 2.07% |
| Context Capital Management, LLC | 1,000,000 | $997,000 | 0.56% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $33,442,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,991,000 | 0.22% |
| CSS LLC/IL | 2,876,000 | $2,883,000 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,016,000 | 0.15% |
| HBK INVESTMENTS L P | 10,116,000 | $10,186,000 | 0.13% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $1,835,000 | 0.11% |
| LINDEN ADVISORS LP | 6,269,000 | $6,290,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $15,028,000 | 0.02% |